Clinical Trials Browser

Phase 2 × Sleep Disorders, Circadian Rhythm × Melatonin × Clear all

NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Phase 2 Completed

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm